References
- Mitrovic S, Fautrel B. Complications of adult-onset Still’s disease and their management. Expert Rev Clin Immunol. 2018;14:351–365.
- Okwuosa TM, Lee EW, Starosta M, et al. Purtscher-like retinopathy in a patient with adult-onset Still’s disease and concurrent thrombotic thrombocytopenic purpura. Arthritis Rheum. 2007;57:182–185.
- Zafrani L, Mariotte E, Darmon M, et al. Acute renal failure is prevalent in patients with thrombotic thrombocytopenic purpura associated with low plasma ADAMTS13 activity. J Thromb Haemost. 2015;13:380–389.
- Portolés J, de Tomás E, Espinosa A, et al. Thrombotic thrombocytopenic purpura and acute renal failure in adult Still’s disease. Nephrol Dial Transplant. 1997;12:1471–1473.
- Néel A, Wahbi A, Tessoulin B, et al. diagnostic and management of life-threatening adult-onset Still disease: a French nationwide multicenter study and systematic literature review. Crit Care. 2018;22:88.
- El Karoui K, Karras A, Lebrun G, et al. Thrombotic microangiopathy and purtscher-like retinopathy associated with adult-onset Still’s disease: a role for glomerular vascular endothelial growth factor? Arthritis Rheum. 1609–1613;2009(61):1609–1613.
- Quéméneur T, Noel L-H, Kyndt X, et al. Thrombotic microangiopathy in adult Still’s disease. Scand J Rheumatol. 2005;34:399–403.
- Masuyama A, Kobayashi H, Kobayashi Y, et al. A case of adult-onset Still’s disease complicated by thrombotic thrombocytopenic purpura with retinal microangiopathy and rapidly fatal cerebral edema. Mod Rheumatol. 2013;23:379–385.
- Robert V, Eszto P, Perrotez J-L, et al. [Treatment by plasmapheresis of a thrombotic thrombocytopenic purpura associated to a Still’s disease: a case report]. Ann Fr Anesth Reanim. 2006;25:532–534.
- Carron P-L, Cartier J-C, Truche A-S, et al. Complement alternative pathway activation in the course of thrombotic microangiopathy associated with adult-onset Still’s disease. Transfus Apher Sci. 2013;49:533–534.
- Perez MGV, Rodwig FR. Chronic relapsing thrombotic thrombocytopenic purpura in adult onset Still’s disease. South Med J. 2003;96:46–49.
- Kuo H-L, Huang D-F, Lee A-F. Thrombotic microangiopathy in a patient with adult onset Still’s disease. J Clin Rheumatol. 2002;8:276–280.
- Wang H-P, Chen H-A, Chen C-H, et al. Adult Still’s disease patient developed thrombotic microangiopathy with diffuse digital gangrene. Scand J Rheumatol. 2007;36:76–78.
- Gopal M, Cohn CD, McEntire MR, et al. Thrombotic thrombocytopenic purpura and adult onset Still’s disease. Am J Med Sci. 2009;337:373–376.
- Fremeaux-Bacchi V, Fakhouri F, Garnier A, et al. Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults. Clin J Am Soc Nephrol. 2013;8:554–562.
- Peyvandi F, Scully M, Kremer Hovinga JA, et al. Caplacizumab for acquired thrombotic thrombocytopenic purpura. N Engl J Med. 2016;374:511–522.
- Scully M, Cataland SR, Peyvandi F, et al. Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura. N Engl J Med. 2019;380:335–346.
- Joly BS, Coppo P, Veyradier A. An update on pathogenesis and diagnosis of thrombotic thrombocytopenic purpura. Expert Rev Hematol. 2019;12:383–395.
- Mazepa MA, Masias C, Chaturvedi S. How targeted therapy disrupts the treatment paradigm for acquired TTP: the risks, benefits, and unknowns. Blood. 2019;134:415–420.